venlafaxine hydrochloride has been researched along with Anxiety in 56 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (7.14) | 18.2507 |
| 2000's | 20 (35.71) | 29.6817 |
| 2010's | 27 (48.21) | 24.3611 |
| 2020's | 5 (8.93) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, C; Hobbs, G; Signorelli, J | 1 |
| Lenze, EJ; Miller, JP; Mulsant, BH; Nicol, G; Reynolds, CF; Saade, YM; Wetherell, JL; Yingling, M | 1 |
| Belovičová, K; Bögi, E; Dubovický, M; Noguera, MV; Šimončičová, E | 1 |
| Gavrilova, SI; Safarova, TP | 1 |
| Masson, S; Medam, T; Metz, D | 1 |
| Salanio, DM; Stanton, JED; Taylor, R; Wild, EJ | 1 |
| Amsterdam, JD; DeRubeis, RJ; Lorenzo-Luaces, L | 1 |
| Belovicová, K; Bogi, E; Dubovicky, M; Garafová, A; Jezova, D; Koprdova, R; Mach, M; Ujhazy, E; Zilava, L | 1 |
| Gotlib, IH; Kircanski, K; Williams, LM | 1 |
| Allgulander, C; Bandelow, B; Lyndon, GJ; Prieto, R; Wajsbrot, DB | 1 |
| Montgomery, SA | 1 |
| Braund, TA; Harris, AWF; Palmer, DM; Williams, LM | 1 |
| Huang, S; Li, W; Liu, X; Xu, H; Zhang, B | 1 |
| Assié, MB; Auclair, AL; Bardin, L; Cussac, D; Depoortère, R; Heusler, P; Marien, M; Martel, JC; Newman-Tancredi, A; O'Connor, JA | 1 |
| Asarnow, JR; Birmaher, B; Brent, DA; Clarke, GN; Emslie, GJ; He, J; Hilton, RC; Keller, MB; Mansoor, B; Mayes, T; Porta, G; Rengasamy, M; Ryan, N; Shamseddeen, W; Wagner, KD | 1 |
| Charoenphandhu, J; Charoenphandhu, N; Lapmanee, S | 1 |
| Auinger, P; Christine, CW; Factor, SA; Juncos, J; Leentjens, AF; Lyness, JM; Marsh, L; McDonald, W; Moonen, AJ; Panisset, M; Pfeiffer, R; Richard, IH; Rottenberg, D; Serrano Ramos, C; Shulman, L; Singer, C; Slevin, J; Wijers, A | 1 |
| Filippov, G; Gislum, M; Montgomery, S; Wang, G | 1 |
| Arnow, BA; Blasey, C; Etkin, A; Kulkarni, J; Luther, JF; Palmer, DM; Rekshan, W; Rush, AJ; Schatzberg, AF; Williams, LM | 1 |
| Fancourt, N; Ging, JM; Nelson, TY; Sharma, R; Tantsis, EM; Tran, MM | 1 |
| Guo, L; Jiang, HF; Wang, Y; Zhang, A; Zhen, XC; Zheng, LT | 1 |
| Aizenstein, HJ; Anderson, SJ; Blumberger, D; Butters, MA; Dew, MA; Diniz, BS; Kaneriya, SH; Karp, JF; Lenze, EJ; Lotrich, F; Mulsant, BH; Reynolds, CF; Robbins-Welty, GA; Smagula, SF | 1 |
| Chang, LR; Chen, IM; Chen, TT; Huang, WL; Kuo, TB; Liao, SC; Yang, CC | 1 |
| Bech, P; Carlsson, J; Elklit, A; Mortensen, EL; Sonne, C | 1 |
| Garg, R; Kumar, A | 1 |
| Garg, R; Gaur, V; Kumar, A; Kumar, P | 2 |
| Anghelescu, IG; Dierkes, W; Loeschmann, PA; Schmitt, AB; Volz, HP | 1 |
| Kim, JH; Kim, JJ; Kim, S; Lee, H; Lee, JH; Min, BH; Rhee, JC; Rhee, PL; Son, HJ; Suh, YJ | 1 |
| Katiyar, S; Kukade, G; Mahesh, R; Pandey, DK; Rudra, A; Viyogi, S | 1 |
| Bacq, A; Balasse, L; Biala, G; Chevarin, C; Gardier, AM; Gautron, S; Giros, B; Guiard, B; Hamon, M; Louis, F; Martres, MP; Schinkel, A; Vialou, V | 1 |
| Charoenphandhu, J; Charoenphandhu, N; Krishnamra, N; Lapmanee, S | 1 |
| Aquino, TD; Lohoff, FW; Multani, PK; Narasimhan, S; Rickels, K | 1 |
| Delagrange, P; Elizalde, N; García-García, AL; Tordera, RM; Venzala, E | 1 |
| Gibson-Helm, M; Sayakhot, P; Teede, HJ; Vincent, A | 1 |
| Entsuah, R; Hackett, D; Silverstone, PH | 1 |
| Ak, I; Aksu, G; Sayar, K; Tosun, M | 1 |
| Liappas, J; Paparrigopoulos, T; Rabavilas, A; Tzavellas, E | 1 |
| de Guzman, MH; Goldberg, I; Ong, PY; Thiagalingam, S | 1 |
| Bourin, M; Hascoët, M; Nic Dhonnchadha, BA; Ripoll, N; Sébille, V | 1 |
| Bourin, M; Hascoët, M; Massé, F | 1 |
| Ahokas, A; Bradwejn, J; Emilien, G; Salinas, E; Stein, DJ; Whitaker, T | 1 |
| Peres, MF; Vieira, DS | 1 |
| Akgoz, S; Akkaya, C; Eker, SS; Kirli, S; Sivrioglu, EY | 1 |
| Dhir, A; Kulkarni, SK | 1 |
| Aparicio, N; De Boer, WA; Jansen, JB; Laheij, RJ; Tan, AC; Van den Hazel, S; van Kerkhoven, LA; Witteman, BJ | 1 |
| Blanchard, C; Bourin, M; Danjou, P; Hackett, D; Lecrubier, Y; Moon, CA; Schifano, F | 1 |
| Chitra, R; Entsuah, R; Rudolph, RL | 1 |
| Boyd, IW | 1 |
| Albano, D; Amchin, J; Klockowski, PM; Taylor, KP; Zarycranski, W | 1 |
| Ninan, PT | 1 |
| Perry, CM; Wellington, K | 1 |
| Morrow, TJ | 1 |
| Berndt, ER; Crown, WH; Finkelstein, SN; Ling, D; Wan, GJ | 1 |
| Biggio, G; Dazzi, L; Ladu, S; Seu, E; Vacca, G; Vignone, V | 1 |
4 review(s) available for venlafaxine hydrochloride and Anxiety
| Article | Year |
|---|---|
A meta-analysis of the effects of venlafaxine on anxiety associated with depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1998 |
Use of venlafaxine in other psychiatric disorders.
Topics: Anxiety; Attention Deficit Disorder with Hyperactivity; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Fibromyalgia; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Trichotillomania; Venlafaxine Hydrochloride | 2000 |
Venlafaxine extended-release: a review of its use in the management of major depression.
Topics: Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Interactions; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |
The pharmacoeconomics of venlafaxine in depression.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety; Cost-Benefit Analysis; Cyclohexanols; Depression; Drug Utilization Review; Humans; Managed Care Programs; Selective Serotonin Reuptake Inhibitors; United States; Venlafaxine Hydrochloride | 2001 |
19 trial(s) available for venlafaxine hydrochloride and Anxiety
| Article | Year |
|---|---|
Comorbid anxiety in late-life depression: Relationship with remission and suicidal ideation on venlafaxine treatment.
Topics: Aged; Antidepressive Agents; Anxiety; Anxiety Disorders; Depression; Depressive Disorder, Major; Female; Humans; Logistic Models; Male; Middle Aged; Suicidal Ideation; Survival Analysis; Venlafaxine Hydrochloride | 2019 |
Residual anxiety may be associated with depressive relapse during continuation therapy of bipolar II depression.
Topics: Adult; Antidepressive Agents; Anxiety; Bipolar Disorder; Double-Blind Method; Female; Humans; Lithium Compounds; Male; Recurrence; Treatment Outcome; Venlafaxine Hydrochloride | 2018 |
Heart rate variability as a biomarker of anxious depression response to antidepressant medication.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Biomarkers; Citalopram; Depression; Depressive Disorder, Major; Female; Heart Rate; Humans; Male; Middle Aged; Prognosis; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2019 |
Efficacy of venlafaxine extended release in major depressive disorder patients: effect of baseline anxiety symptom severity.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Anxiety Disorders; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride | 2019 |
Dimensions of anxiety in Major depressive disorder and their use in predicting antidepressant treatment outcome: an iSPOT-D report.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Citalopram; Cognition; Depressive Disorder, Major; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychometrics; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2020 |
Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.
Topics: Adolescent; Anxiety; Attention Deficit and Disruptive Behavior Disorders; Behavioral Symptoms; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Treatment-Resistant; Fluoxetine; Humans; Paroxetine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Comparison of vortioxetine versus venlafaxine XR in adults in Asia with major depressive disorder: a randomized, double-blind study.
Topics: Adolescent; Adult; Aged; Anxiety; Asia; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sulfides; Venlafaxine Hydrochloride; Vortioxetine; Young Adult | 2015 |
Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.
Topics: Adult; Antidepressive Agents; Anxiety; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Outpatients; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety; Aripiprazole; Comorbidity; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Executive Function; Female; Follow-Up Studies; Humans; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors; Set, Psychology; Severity of Illness Index; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride | 2016 |
Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Denmark; Depression; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Quality of Life; Refugees; Research Design; Sertraline; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2016 |
Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial.
Topics: Adult; Anxiety; Chest Pain; Chi-Square Distribution; Cross-Over Studies; Cyclohexanols; Delayed-Action Preparations; Depression; Double-Blind Method; Esophageal Diseases; Esophageal pH Monitoring; Female; Humans; Male; Manometry; Placebos; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Variation in the catechol-O-methyltransferase (COMT) gene and treatment response to venlafaxine XR in generalized anxiety disorder.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Anxiety; Catechol O-Methyltransferase; Cyclohexanols; Female; Gene Frequency; Genotype; Humans; Male; Middle Aged; Mutation; Pharmacogenetics; Venlafaxine Hydrochloride; Young Adult | 2012 |
Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine.
Topics: Adolescent; Adult; Affect; Aged; Aged, 80 and over; Anxiety; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Placebos; Predictive Value of Tests; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Venlafaxine treatment of fibromyalgia.
Topics: Adrenergic Uptake Inhibitors; Adult; Anxiety; Cyclohexanols; Depression; Female; Fibromyalgia; Humans; Pain; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Central Nervous System Depressants; Cyclohexanols; Depressive Disorder; Ethanol; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Patient Dropouts; Psychiatric Status Rating Scales; Socioeconomic Factors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2005 |
Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study.
Topics: Adult; Analysis of Variance; Anxiety; Capsules; Cholesterol; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Fear; Female; Heart Rate; Humans; Male; Panic Disorder; Patient Compliance; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Severity of Illness Index; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Depression; Double-Blind Method; Dyspepsia; Female; Humans; Male; Middle Aged; Placebos; Quality of Life; Venlafaxine Hydrochloride | 2008 |
Efficacy of venlafaxine in depressive illness in general practice.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety; Cyclohexanols; Depression; Double-Blind Method; Family Practice; Female; Humans; Imipramine; Male; Middle Aged; Placebo Effect; Prospective Studies; Social Adjustment; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
33 other study(ies) available for venlafaxine hydrochloride and Anxiety
| Article | Year |
|---|---|
Anxiety exacerbation in a patient with chronic myeloid leukemia receiving dasatinib and venlafaxine.
Topics: Aged; Anxiety; Dasatinib; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Protein Kinase Inhibitors; Quality of Life; Sleep Initiation and Maintenance Disorders; Venlafaxine Hydrochloride | 2023 |
Long-term effects of pre-gestational stress and perinatal venlafaxine treatment on neurobehavioral development of female offspring.
Topics: Animals; Anxiety; Behavior, Animal; Disease Models, Animal; Female; Hippocampus; Lactation; Maternal Behavior; Maze Learning; Postpartum Period; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Serotonin and Noradrenaline Reuptake Inhibitors; Sex Factors; Stress, Psychological; Venlafaxine Hydrochloride | 2021 |
[The use of neuroprotectors in the treatment of late depression].
Topics: Aged; Antidepressive Agents; Anxiety; Depression; Depressive Disorder; Humans; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride | 2020 |
Double-blind, placebo-controlled trial of venlafaxine to treat behavioural disorders in cats: a pilot study.
Topics: Animals; Anxiety; Cats; Double-Blind Method; Fear; Pilot Projects; Treatment Outcome; Venlafaxine Hydrochloride | 2022 |
Ghost Pills: A Case Report.
Topics: Aged; Antidepressive Agents, Second-Generation; Anxiety; Delayed-Action Preparations; Depression; Feces; Humans; Huntington Disease; Male; Venlafaxine Hydrochloride | 2017 |
Perinatal exposure to venlafaxine leads to lower anxiety and depression-like behavior in the adult rat offspring.
Topics: Adrenal Cortex Hormones; Aldosterone; Animals; Animals, Newborn; Anxiety; Anxiety Disorders; Behavior, Animal; Brain; Corticosterone; Depression; Depressive Disorder; Female; Fluoxetine; Hippocampus; Male; Maternal Behavior; Postpartum Period; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Venlafaxine Hydrochloride | 2018 |
Depression with high levels of anxiety.
Topics: Anxiety; Anxiety Disorders; Depression; Depressive Disorder, Major; Humans; Venlafaxine Hydrochloride | 2019 |
Long-term estrogen deprivation changes the response to antianxiety drugs in mice in the elevated plus maze test.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Buspirone; Diazepam; Estrogens; Mice; Ovariectomy; Venlafaxine Hydrochloride | 2019 |
Levomilnacipran (F2695), a norepinephrine-preferring SNRI: profile in vitro and in models of depression and anxiety.
Topics: Adrenergic Uptake Inhibitors; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal; Cerebral Cortex; Cyclohexanols; Cyclopropanes; Depression; Dopamine; Duloxetine Hydrochloride; Humans; Male; Mice; Milnacipran; Motor Activity; Neurotransmitter Transport Proteins; Norepinephrine; Rats; Serotonin; Synaptosomes; Thiophenes; Venlafaxine Hydrochloride | 2013 |
Beneficial effects of fluoxetine, reboxetine, venlafaxine, and voluntary running exercise in stressed male rats with anxiety- and depression-like behaviors.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Cyclohexanols; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Male; Maze Learning; Morpholines; Physical Conditioning, Animal; Rats; Rats, Wistar; Reboxetine; Restraint, Physical; Running; Stress, Psychological; Sucrose; Swimming; Venlafaxine Hydrochloride | 2013 |
Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.
Topics: Aged; Antidepressive Agents; Anxiety; Cyclohexanols; Datasets as Topic; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Paroxetine; Predictive Value of Tests; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Severity of Illness Index; Venlafaxine Hydrochloride | 2014 |
Failure to thrive potentially secondary to maternal venlafaxine use.
Topics: Antidepressive Agents, Second-Generation; Anxiety; Body Weight; Breast Feeding; Depression; Failure to Thrive; Female; Humans; Infant, Newborn; Pregnancy; Venlafaxine Hydrochloride | 2016 |
Allosteric Modulation of Sigma-1 Receptors Elicits Rapid Antidepressant Activity.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Anxiety; Benzazepines; Brain-Derived Neurotrophic Factor; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme Inhibitors; Gene Expression Regulation; Hippocampus; Immobility Response, Tonic; Male; Mice; Mice, Inbred C57BL; Neurons; Phenazocine; Receptors, sigma; Sigma-1 Receptor; Signal Transduction; Stress, Psychological; Swimming; Time Factors; Venlafaxine Hydrochloride | 2016 |
The Effects of Antidepressants and Quetiapine on Heart Rate Variability.
Topics: Adult; Aged; Antidepressive Agents; Anxiety; Depression; Female; Heart Rate; Humans; Linear Models; Male; Medically Unexplained Symptoms; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Sertraline; Taiwan; Venlafaxine Hydrochloride | 2016 |
A role of nitric oxide mechanism involved in the protective effects of venlafaxine in sleep deprivation.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Arginine; Behavior, Animal; Cyclohexanols; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Lipid Peroxidation; Maze Learning; Methylene Blue; Mice; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Reaction Time; Sleep Deprivation; Venlafaxine Hydrochloride | 2008 |
Nitric oxide mechanism in protective effect of imipramine and venlafaxine against acute immobilization stress-induced behavioral and biochemical alteration in mice.
Topics: Animals; Antidepressive Agents; Anxiety; Arginine; Behavior, Animal; Cyclohexanols; Drug Synergism; Imipramine; Immobilization; Mice; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Pain Measurement; Stress, Psychological; Venlafaxine Hydrochloride | 2009 |
[Therapeutic effects of venlafaxine extended release for patients with depressive and anxiety disorders in the German outpatient setting - results of 2 observational studies including 8500 patients].
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Female; Germany; Humans; Male; Middle Aged; Outpatients; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Venlafaxine involves nitric oxide modulatory mechanism in experimental model of chronic behavior despair in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Arginine; Caffeine; Central Nervous System Stimulants; Chronic Disease; Cyclohexanols; Depressive Disorder; Disease Models, Animal; Enzyme Inhibitors; Male; Methylene Blue; Mice; Mice, Inbred Strains; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Random Allocation; Swimming; Venlafaxine Hydrochloride | 2010 |
Effect of anti-depressants on neuro-behavioural consequences following impact accelerated traumatic brain injury in rats.
Topics: Acceleration; Amitriptyline; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Brain Injuries; Bupropion; Citalopram; Cyclohexanols; Exploratory Behavior; Fear; Male; Neuronal Plasticity; Neurotransmitter Uptake Inhibitors; Norepinephrine; Rats; Rats, Wistar; Reflex, Startle; Serotonin; Social Behavior; Venlafaxine Hydrochloride | 2010 |
Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response.
Topics: Action Potentials; Animals; Antidepressive Agents, Second-Generation; Anxiety; Brain; Corticosterone; Cyclohexanols; Depression; Disease Models, Animal; Female; Hippocampus; Limbic System; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Imaging; Norepinephrine; Organic Cation Transport Proteins; Organic Cation Transporter 2; Radioligand Assay; Serotonin; Venlafaxine Hydrochloride | 2012 |
Anxiolytic-like actions of reboxetine, venlafaxine and endurance swimming in stressed male rats.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Cyclohexanols; Male; Morpholines; Motor Activity; Physical Conditioning, Animal; Rats; Rats, Wistar; Reboxetine; Restraint, Physical; Stress, Physiological; Stress, Psychological; Swimming; Venlafaxine Hydrochloride | 2012 |
Chronic social defeat stress model: behavioral features, antidepressant action, and interaction with biological risk factors.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Cyclohexanols; Depression; Depressive Disorder; Disease Models, Animal; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Risk Factors; RNA, Messenger; Social Behavior; Stress, Psychological; Thiazepines; Venlafaxine Hydrochloride; Vesicular Glutamate Transport Protein 1 | 2012 |
Differences in clinician understanding and management of early menopause after breast cancer.
Topics: Anxiety; Australia; Breast Neoplasms; Cross-Sectional Studies; Cyclohexanols; Depression; Endocrinology; Exercise; Female; Follicle Stimulating Hormone; General Practitioners; General Surgery; Gynecology; Hot Flashes; Humans; Life Style; Medical Oncology; Menopause, Premature; Practice Patterns, Physicians'; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2013 |
Venlafaxine: not yet first in the antidepressant class.
Topics: Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Humans; Remission Induction; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Bilateral acute angle closure caused by supraciliary effusions associated with venlafaxine intake.
Topics: Adult; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Anxiety; Ciliary Body; Cyclohexanols; Depression; Glaucoma, Angle-Closure; Gonioscopy; Humans; Iris; Male; Microscopy, Acoustic; Ocular Hypertension; Venlafaxine Hydrochloride | 2005 |
The four-plates test-retest paradigm to discriminate anxiolytic effects.
Topics: Adrenergic Uptake Inhibitors; Amphetamines; Animals; Anti-Anxiety Agents; Anxiety; Atropine; Avoidance Learning; Behavior, Animal; Benzodiazepines; Cholinergic Agents; Cyclohexanols; Discrimination, Psychological; Dose-Response Relationship, Drug; Male; Mice; Paroxetine; Receptors, GABA-A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Venlafaxine Hydrochloride | 2005 |
alpha2-Adrenergic agonists antagonise the anxiolytic-like effect of antidepressants in the four-plate test in mice.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Citalopram; Clonidine; Cyclohexanols; Cyclopropanes; Dose-Response Relationship, Drug; Drug Antagonism; Guanabenz; Male; Mice; Milnacipran; Motor Activity; Paroxetine; Punishment; Selective Serotonin Reuptake Inhibitors; Statistics, Nonparametric; Venlafaxine Hydrochloride | 2005 |
Tension-type headache with aura.
Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Bromazepam; Cyclohexanols; Fructose; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Tension-Type Headache; Topiramate; Venlafaxine Hydrochloride; Vision Disorders | 2006 |
Venlafaxine reverses chronic fatigue-induced behavioral, biochemical and neurochemical alterations in mice.
Topics: Adrenergic Uptake Inhibitors; Animals; Anxiety; Behavior, Animal; Cyclohexanols; Disease Models, Animal; Dopamine; Fatigue Syndrome, Chronic; Glutathione; Lipid Peroxidation; Male; Maze Learning; Memory; Mice; Motor Activity; Norepinephrine; Oxidative Stress; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2008 |
Venlafaxine withdrawal reactions.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Depression; Depressive Disorder; Dizziness; Fatigue; Female; Hallucinations; Headache; Humans; Male; Middle Aged; Nausea; Sensation Disorders; Substance Withdrawal Syndrome; Tinnitus; Venlafaxine Hydrochloride | 1998 |
Effect of venlafaxine on the pharmacokinetics of risperidone.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety; Area Under Curve; Cyclohexanols; Desvenlafaxine Succinate; Exploratory Behavior; Female; Humans; Isoxazoles; Male; Metabolic Clearance Rate; Middle Aged; Paliperidone Palmitate; Psychomotor Performance; Pyrimidines; Risperidone; Venlafaxine Hydrochloride | 1999 |
Treatment costs of venlafaxine and selective serotonin-reuptake inhibitors for depression and anxiety.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Depressive Disorder; Drug Costs; Female; Health Care Costs; Humans; Longitudinal Studies; Male; Managed Care Programs; Middle Aged; Patient Compliance; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; United States; Venlafaxine Hydrochloride | 2002 |
Inhibition by venlafaxine of the increase in norepinephrine output in rat prefrontal cortex elicited by acute stress or by the anxiogenic drug FG 7142.
Topics: Animals; Anxiety; Carbolines; Cyclohexanols; Dose-Response Relationship, Drug; Electroshock; Extracellular Space; GABA Agonists; Male; Microdialysis; Norepinephrine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Venlafaxine Hydrochloride | 2002 |